CD14 and tuberculosis: Although pharmacological therapy was reported to reduce the accumulation of myeloid cell populations [51,52,53], Amiano et al. observed a restoration in CD14++CD16+ and CD14+CD16++ monocytes and M-MDSC after anti-TB treatment.